美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Vivos Inc.

0.0698

-0.0021-2.92%

成交量：43.01萬

成交額：3.11萬

市值：3,445.61萬

市盈率：-9.32

高：0.0747

開：0.0720

低：0.0663

收：0.0719

52周最高：0.1547

52周最低：0.0425

股本：4.94億

流通股本：4.34億

量比：0.82

換手率：0.10%

股息：- -

股息率：- -

每股收益(TTM):-0.0075

每股收益(LYR):-0.0043

淨資產收益率：-116.12%

總資產收益率：-56.92%

市淨率：-5.18

市盈率(LYR):-16.25

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

Vivos Inc. 宣佈在向FDA提交Radiogel®精準放射性核素療法™研究器械豁免申請方面取得重大進展

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/RDGL"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RDGL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RDGL\",,,,,undefined,":{"symbol":"RDGL","market":"US","secType":"STK","nameCN":"Vivos Inc.","latestPrice":0.0698,"timestamp":1779480000000,"preClose":0.0719,"halted":0,"volume":430061,"delay":15,"changeRate":-0.029207232267037614,"floatShares":434000000,"shares":493640608,"eps":-0.007488,"marketStatus":"盤前交易","change":-0.0021,"latestTime":"05-22 16:00:00 EDT 延時","open":0.072,"high":0.0747,"low":0.0663,"amount":31058.64566000001,"amplitude":0.116829,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.007488,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1779802200000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"OTCQB","adjPreClose":0.0698,"volumeRatio":0.8163161874356566},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RDGL\",,,,,undefined,":{"symbol":"RDGL","floatShares":434000000,"roa":"-56.92%","roe":"-116.12%","lyrEps":-0.004295,"volumeRatio":0.8163161874356566,"shares":493640608,"dividePrice":0,"high":0.0747,"amplitude":0.116829,"preClose":0.0719,"low":0.0663,"week52Low":0.0425,"pbRate":"-5.18","psRate":"443.46","week52High":0.1547,"institutionHeld":0,"latestPrice":0.0698,"eps":-0.007488,"divideRate":0,"volume":430061,"delay":15,"ttmEps":-0.007488,"open":0.072,"prevYearClose":0.0689,"prevWeekClose":0.0698,"prevMonthClose":0.0691,"prevQuarterClose":0.0899,"fiveDayClose":0.0678,"twentyDayClose":0.07,"sixtyDayClose":0.0848},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RDGL\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-11-13","symbol":"RDGL","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-08-13","symbol":"RDGL","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-05-09","symbol":"RDGL","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-03-18","symbol":"RDGL","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1710734400000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2023-11-06","symbol":"RDGL","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1699246800000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RDGL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RDGL\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RDGL\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1172695555","title":"Vivos Inc. 宣佈在向FDA提交Radiogel®精準放射性核素療法™研究器械豁免申請方面取得重大進展","url":"https://stock-news.laohu8.com/highlight/detail?id=1172695555","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172695555?lang=zh_tw&edition=fundamental","pubTime":"2026-02-10 21:33","pubTimestamp":1770730414,"startTime":"0","endTime":"0","summary":"Vivos Inc. 近日宣布，公司在为其核心产品Radiogel®精准放射性核素疗法™向美国食品药品监督管理局（FDA）提交研究器械豁免（IDE）申请的工作中，取得了显著进展。这一关键里程碑标志着该疗法向临床应用迈出了重要一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RDGL","BK4082"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/RDGL\",params:#limit:6,delay:false,,,undefined,":[]}}